Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-05-30 4:15 pm Purchase | 13D | SOLENO THERAPEUTICS INC PA SLNO | PERCEPTIVE ADVISORS LLC | 2,029,455 24.8% | 85,000 (+4.37%) | View |
2023-05-26 1:14 pm Purchase | 13D | SOLENO THERAPEUTICS INC PA SLNO | SCHULER JACK W | 421,976 4.99% | 421,976 (New Position) | View |
2023-05-25 4:58 pm Purchase | 13D | SOLENO THERAPEUTICS INC PA SLNO | PERCEPTIVE ADVISORS LLC | 1,944,455 23.8% | 80,000 (+4.29%) | View |
2023-05-18 4:32 pm Purchase | 13D | SOLENO THERAPEUTICS INC PA SLNO | PERCEPTIVE ADVISORS LLC | 1,864,455 22.8% | 1,864,455 (New Position) | View |
2023-05-15 5:02 pm Purchase | 13G | SOLENO THERAPEUTICS INC NE SLNO | Vivo Opportunity Fund Holdings L.P. | 8,418,093 19.99% | 8,418,093 (New Position) | View |
2023-05-10 4:32 pm Unchanged | 13D | SOLENO THERAPEUTICS INC NE SLNO | Carlyle Group Inc. CG | 0 0% | 0 (Unchanged) | View |
2023-02-15 07:26 am Sale | 13G | SOLENO THERAPEUTICS INC NE SLNO | HIRSCHMAN ORIN | 422,489 5.2% | -6,377,511 (-93.79%) | View |
2023-02-14 5:06 pm Sale | 13G | SOLENO THERAPEUTICS INC NE SLNO | Nantahala Capital Management LLC | 838,534 9.9% | -8,926,595 (-91.41%) | View |
2022-12-20 4:30 pm Sale | 13D | SOLENO THERAPEUTICS INC NE SLNO | Carlyle Group Inc. CG | 0 0% | -18,368,564 (Position Closed) | View |
2022-08-11 4:56 pm Purchase | 13D | SOLENO THERAPEUTICS INC NE SLNO | Carlyle Group Inc. CG | 18,368,564 15.3% | 18,368,564 (New Position) | View |
2022-04-08 4:35 pm Purchase | 13D | SOLENO THERAPEUTICS INC NE SLNO | Abingworth LLP | 18,368,373 15.3% | 7,823,974 (+74.20%) | View |
2022-04-05 4:01 pm Sale | 13D | SOLENO THERAPEUTICS INC NE SLNO | Jack W. Schuler Living Trust | 11,911,804 9.6% | -733,168 (-5.80%) | View |
2022-04-05 08:05 am Purchase | 13G | SOLENO THERAPEUTICS INC NE SLNO | HIRSCHMAN ORIN | 6,800,000 5.7% | 6,800,000 (New Position) | View |
2022-02-14 08:22 am Unchanged | 13G | SOLENO THERAPEUTICS INC NE SLNO | Nantahala Capital Management LLC | 9,765,129 12.2% | 0 (Unchanged) | View |
2022-02-11 4:55 pm Sale | 13G | SOLENO THERAPEUTICS INC NE SLNO | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0% | -5,758,200 (Position Closed) | View |
2021-07-12 4:01 pm Purchase | 13G | SOLENO THERAPEUTICS INC NE SLNO | Nantahala Capital Management LLC | 9,765,129 12.2% | 1,893,773 (+24.06%) | View |
2021-02-16 4:02 pm Sale | 13G | SOLENO THERAPEUTICS INC NE SLNO | FEINBERG LARRY N | 3,732,640 4.7% | -1,967,407 (-34.52%) | View |
2021-02-12 3:22 pm Purchase | 13G | SOLENO THERAPEUTICS INC NE SLNO | Nantahala Capital Management LLC | 7,871,356 9.9% | 3,593,433 (+84.00%) | View |
2020-11-09 4:46 pm Purchase | 13G | SOLENO THERAPEUTICS INC NE SLNO | SUVRETTA CAPITAL MANAGEMENT LLC | 5,758,200 7.2% | 5,758,200 (New Position) | View |
2020-07-16 7:10 pm Purchase | 13D | SOLENO THERAPEUTICS INC NE SLNO | Jack W. Schuler Living Trust | 12,644,972 15.65% | 6,818,184 (+117.01%) | View |